ANRis: Funding, Investors & Team (Sep 2026)
ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
ANRis has raised $1.4M across 1 funding round on record, the most recent an undisclosed round of $1.4M announced in Sep 2026.
That round is below the $4.2M median round size for Japan companies tracked on FundedIQ over the last two years.
ANRis Company Profile and Key Stats
Latest funding round on record: Sep 2026.
ANRis Funding Rounds
ANRis Investors
ANRis Funding in Context
ANRis' latest round of $1.4M is below the median round in Japan. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ANRis in Biotechnology and Tokyo
Companies Similar to ANRis
Albatross Technology is a IT company that develops offshore renewable energy devices and floating offshore…
Aitane is a technology company specializing in AI agents that automate sales administration tasks such as CRM…
Akiya's primary business is the purchase, remodeling, and rental of unoccupied homes.
POLASTECH is a deep tech company aiming to innovate cooling energy in data centers and industrial sectors.
SiccaNova Therapeuticsis a startup developing novel low-molecular therapeutics targeting dry mouth…
PeopleX is an HR solutions platform that offers an AI interviewer, skills development, a meeting tool, and…
Power Laser is a tech company that develops cutting-edge power laser technology and applications for various…
Metro Weather is a technology company that develops and manufactures Doppler LIDAR to visualize atmospheric…
SUNSHIKI is a green tech startup that offers seaweed technology to develop seaweed-based products.
Paytner is a finance firm that provides factoring services to support freelance people's funding.
KG Motors is an automotive firm that manufactures electric vehicles that can be moved comfortably and safely…
ByFood connects travelers with Japan’s best food experiences and restaurants while donating meals to children…
ANRis Funding FAQs
What does ANRis do?
ANRis is a hybrid drug discovery venture that develops medicines to provide medical care for patients with cancer and genetic diseases.
How much funding has ANRis raised?
ANRis has raised $1.4M across 1 round on record. The most recent is an undisclosed round of $1.4M announced in Sep 2026.
When did ANRis last raise funding?
ANRis' most recent funding round on record is an undisclosed round of $1.4M, announced in Sep 2026.
Who has invested in ANRis?
Investors on record for ANRis include Japan Science and Technology Agency, WASEDA University Ventures.
Where is ANRis headquartered?
ANRis is based in Tokyo, Japan.
How many employees does ANRis have?
ANRis is in the 1-10 employee band.
About FundedIQ's ANRis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ANRis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.